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Ablation-catheter
Immediate Improvement in Coronary Flow Reserve After 
Alcohol Septal Ablation in Patients With Hypertrophic 
Obstructive Cardiomyopathy##903-213·6B
Adenosine
Immediate Improvement in Coronary Flow Reserve After 
Alcohol Septal Ablation in Patients With Hypertrophic 
Obstructive Cardiomyopathy##903-213·6B
Adverse Events/cardiovascular care
Predictors of Major Vascular Complications in Patients 
Undergoing Percutaneous Coronary Intervention: Insights 
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Aneurysms
Computed Tomography Scan Versus EndoSure™ for Endoleak 
Detection After Endovascular Repair of Abdominal Aortic 
Aneurysm##913-212·27B
Transcatheter Restriction of Left Ventricular Cavity in 
Piglets##907-212·15B
Angina pectoris
Circulating Pregnancy-Associated Plasma Protein-A Levels 
and Long-Term Prognosis in Patients With Chronic Stable 
Angina Pectoris##905-217·11B
Initial Experience and Efficacy of the Retrograde Approach 
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Is Contrast Medium Dose a Risk Factor for the Development 
of Contrast-Induced Nephropathy in Patients With 
Chronic Kidney Disease?##908-209·16B
X-Ray Dose-Awareness in the Interventional Laboratory: 
Interactive Display Improves Safety##910-216·22B
Angiogenesis
Abnormal Neoangiogenesis Evaluated by CD105 
Expression of Endothelial Precursor Cells Is Associated 
With Restenosis After Percutaneous Coronary 
Intervention##917-213·35B
Time-Dependent Inhibition of the Ischemia-Induced 
Mobilization of Bone Marrow Mesenchymal Stem Cells 
by Ischemic Preconditioning During Porcine Coronary 
Occlusion/Reperfusion##2803-3·42B
Angiography
A Prospective, Natural History Study of Multimodality 
Invasive Imaging to Characterize Vulnerable Plaque: First 
Report of the Baseline Findings From the PROSPECT 
Trial##909-210·19B
Incidence of Late Angiographic Stent Thrombosis of 
Sirolimus-Eluting Stents##918-211·37B
Preventing Contrast-Induced Nephropathy in High-Risk 
Patients: Does the Contrast Agent Matter?##906-209·12B
Prevention of Radiocontrast Medium Induced Nephropathy 
Using High-Dose Statin in Patients Undergoing Coronary 
Angiography: The PROMISS Trial - A Randomized 
Controlled Study##2805-7·46B
Radiation Exposure During Flat Detector Fluoroscopy: 
Recognition of a Unique Hazard to Obese Patients##911-
216·24B
Referrals in Acute Coronary Events for Cardiac 
Catheterization, the RACE CAR Study: What 
Factors Account for Gender Differences in Cardiac 
Catheterization Referral Rates?##909-217·20B
The Critical Role of Magnetic Resonance Angiography in 
Evaluation of Anomalous Coronary Arteries##911-
214·23B
The Incidence of Contrast-Induced Nephropathy With 
Iomeprol Is Similar to the Incidence of Contrast-Induced 
Nephropathy With Iopamidol##904-217·9B
Angioplasty
A Prospective Registry to Evaluate an Implantation of 
Sirolimus-Eluting Stent in Bifurcation Lesions: 
Comparison of Simple-Versus Complex Stenting 
Techniques: Long-Term Clinical Outcome From the 
J-Cypher Registry##905-211·10B
A Prospective, Randomized Trial of Bivalirudin in Acute 
Coronary Syndromes: One Year Results From the 
ACUITY Trial##905-210·10B
Bifurcation Lesion Intervention With Cypher and Endeavor 
Drug-Eluting Stents: A Comparison##919-213·39B
Bivalirudin and Heparin Plus Glycoprotein Inhibition Results 
in Similar Mortality and Ischemic Outcomes in Patients 
Undergoing Percutaneous Coronary Intervention: The 
DEScover Registry##905-216·11B
Chronic Kidney Disease Is Associated With Increased 
Mortality, Bleeding, and Ischemic Events in Moderate and 
High-Risk Patients With Acute Coronary Syndromes: An 
ACUITY Substudy##2805-5·45B
Comparative Analysis of Neointimal Growth on the Stent 
Struts of Sirolimus-Eluting Stents and Bare Metal 
Stents Crossing a Side Branch Using Optical Coherence 
Tomography##908-213·17B
Computed Tomography Scan Versus EndoSure™ for Endoleak 
Detection After Endovascular Repair of Abdominal Aortic 
Aneurysm##913-212·27B
Cone Crush, Is a Variant of Modified T-Stenting Technique for 
Coronary Bifurcation Lesions: Bench Testing, Clinical 
Feasibility and In-Hospital Outcomes##903-214·6B
Culotte Versus T-Stenting in Bifurcation Lesions: Immediate 
Clinical and Angiographic Results and Mid-Term Clinical 
Follow-Up##909-214·20B
Does Diabetic Mellitus Predict a Higher In-Hospital 
Mortality Following Percutaneous Saphenous Vein 
Graft Intervention in the Setting of Acute Myocardial 
Infarction?##916-216·34B
Effects of Aspirin Dose on Ischemic Events and Bleeding After 
Percutaneous Coronary Intervention: Insights From the 
PCI-CURE Study##2805-9·46B
Faster Times to Primary Percutaneous Coronary Intervention 
Are Associated With Better Survival: Insights From 
the Assessment of Pexelizumab in Acute Myocardial 
Infarction Trial##2803-5·42B
Feasibility and Safety of Drug-Eluting Stent Implantaton in the 
Treatment of Stenosis of Vertebrobasilar Arteries##919-
212·39B
Five-Year Outcomes in a Cohort of Coronary Artery Disease 
Patients Treated With Percutaneous Coronary Intervention 
in the National Heart Lung and Blood Institute Dynamic 
Registry: Initial Acute Coronary Syndrome Is a Risk 
Factor for Future Ischemic Events##907-210·14B
Four-Year Clinical Follow-Up of the Research 
Registry##2804-9·44B
Impact of an Acute Percutaneous Coronary Intervention on 
Survival Rates for Women With and Without Diabetes 
Admitted to a Community Hospital With Acute 
Myocardial Infarction##913-216·28B
Impact of Glycoprotein IIb/IIIa Inhibitors on Outcomes of 
Diabetic Patients Undergoing Percutaneous Coronary 
Interventions With Sirolimus-Eluting Stents##916-
209·32B
Impact of Multivessel Disease on Long-Term Mortality 
in Patients With ST-Segment Elevation Myocardial 
Infarction With Cardiogenic Shock Treated With 
Percutaneous Coronary Intervention##912-216·26B
Impact of Renal Insufficiency on Clinical Outcomes Following 
Drug-Eluting Stent Implantation##907-209·14B
Impact of Techniques to Reduce or Prevent Distal 
Embolization During Primary Percutaneous Coronary 
Intervention for Acute Myocardial Infarction: Meta-
Analysis of Randomized Clinical Trials##2803-7·43B
Implications of Hemoglobin Decrease in the Absence 
of Overt Bleeding After Percutaneous Coronary 
Intervention##2805-3·45B
Is There a Lack of Initial Benefit With Drug Eluting 
Stents? Insights From 3-Year Follow-Up of ERACI III 
Study##2801-7·40B
Large Myocardial Infarction After Percutaneous Coronary 
Intervention: Secondary to Micro Embolization or Macro 
Mechanical Complications?##910-210·21B
Measures of Aspirin Resistance and Clopidogrel Resistance 
Do Not Correlate With Post-Percutaneous Coronary 
Intervention Markers of Myonecrosis##903-216·7B
Optimal Platelet Inhibition in Patients Undergoing 
Percutaneous Coronary Intervention: Data From the MR 
PCI Study##916-215·34B
Percutaneous Circulatory Support During High-Risk 
Angioplasty Procedures: A Multicenter Experience With 
Impella Technology##901-212·1B
Predictors of Irreversible Events After Percutaneous Coronary 
Intervention in Unprotected Left Main Lesions##904-
214·8B
Primary Percutaneous Coronary Intervention May Improve 
Survival Compared With Thrombolysis in End-Stage 
Renal Dialysis Patients With Prior Ischemic Heart 
Disease##903-209·5B
Radial Versus Femoral Arterial Access in Emergent Coronary 
Interventions for Acute Myocardial Infarction With ST-
Segment Elevation##906-212·12B
Rescue Angioplasty After Failed Fibrinolysis for Acute 
Myocardial Infarction: Predictors of a Failed Procedure 
and 1-Year Mortality##914-216·30B
Robust Impact of Chronic Kidney Disease on Long-Term 
Survival in Patients Undergoing Revascularization 
of Severe Unprotected Left Main Coronary Artery 
Stenosis##905-209·9B
Safety and Efficacy of a New Guidewire for Crossing Chronic 
Total Occlusions: First in Man Results##918-210·36B
Short- and Long-Term Outcomes After Stent-Assisted 
Percutaneous Treatment of Saphenous Vein Grafts 
With Drug-Eluting Stents: Have We Made Any 
Progress?##913-214·27B
ST-Segment Analysis Using Wireless Technology in Acute 
Myocardial Infarction Trial##918-216·38B
The CROSSER Chronic Total Occlusion Recanalization 
System: Multicenter United States and European Study 
Results##915-209·30B
The Effects of Balloon Occlusion and Aspiration Device 
During Primary Percutaneous Coronary Intervention 
on Infarct Size and Remodeling: Mid-Term Contrast-
Enhanced Magnetic Resonance Imaging Follow-
Up##918-214·37B
Time Delay to Rescue Percutaneous Coronary Intervention 
and Clinical Endpoints: Results From the REACT 
Study##911-210·23B
Treatment of Side Branch Plaque Shift in Coronary Bifurcation 
Lesions With Balloon Cryoangioplasty##913-211·27B
Trends in Outcomes Following Percutaneous Coronary 
Intervention for Chronic Total Occlusions: 25-Year 
Experience From the Mayo Clinic##2802-5·41B
True Lumen Re-Entry Catheter Availability Improves 
Procedural Success in Endovascular Intervention of 
Peripheral Chronic Total Occlusions##914-212·29B
What Is the Optimal Definition of Renal Failure After 
Percutaneous Coronary Intervention? Findings From 
the Guthrie Percutaneous Coronary Intervention 
Registry##909-209·18B
What Kind of Polymer Is Better for Bifurcation 
Stenting?##908-214·17B
Angioscopy
Quantitative Analysis of Vulnerable Plaque Color Using LCH 
Color Space##912-213·25B
Superficial Fibro-Fatty Area Detected by Virtual Histology 
Intravascular Ultrasound Is Associated With Thrombus 
Detected by Angioscopy##916-213·33B
Vulnerable and Stable Lesion Characteristics Assessed by 
Optical Coherence Tomography, Integrated-Backscatter 
Intravascular Ultrasound, Angioscopy, and 64-Slice Multi-
Detector Computed Tomography##913-213·27B
Anticoagulants
A Prospective, Randomized Trial of Bivalirudin in Acute 
Coronary Syndromes: One Year Results From the 
ACUITY Trial##905-210·10B
Bivalirudin and Heparin Plus Glycoprotein Inhibition Results 
in Similar Mortality and Ischemic Outcomes in Patients 
Undergoing Percutaneous Coronary Intervention: The 
DEScover Registry##905-216·11B
Chronic Kidney Disease Is Associated With Increased 
Mortality, Bleeding, and Ischemic Events in Moderate and 
High-Risk Patients With Acute Coronary Syndromes: An 
ACUITY Substudy##2805-5·45B
Impact of Combination of Glycoprotein IIb/IIIa Inhibition 
and Bivalirudin on Long-Term Outcomes Following 
Percutaneous Coronary Intervention in Real-World 
Clinical Practice##908-216·18B
Outcomes of Bivalirudin in Moderate-and High-Risk Patients 
With Acute Coronary Syndromes and Renal Insufficiency: 
An ACUITY Substudy##902-216·4B
Should Bivalirudin Be the Preferred Antithrombotic Agent of 
Choice During Elective or Urgent Percutaneous Coronary 
Intervention? A Bayesian Analysis of REPLACE-2 and 
ACUITY Trials##918-215·37B
Aorta
Computed Tomography Scan Versus EndoSure™ for Endoleak 
Detection After Endovascular Repair of Abdominal Aortic 
Aneurysm##913-212·27B
Aortic diseases
Experience With the Self-Expanding 21 French Percutaneous 
CoreValve Aortic Valve Prosthesis in High-Risk and 
Inoperable Patients With Symptomatic Aortic Valve 
Stenosis##2801-9·40B
Aortic regurgitation
Periventricular Nonsurgical Aortic Valve Placement With 
Subsequent Use of Myocardial Plugs##907-213·15B
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Aortic valve stenosis
Three-Year Clinical and Echocardiographic Follow-Up After 
Percutaneous Edwards Aortic Valve Implantation for 
Severe Aortic Stenosis in Compassionate Patients##904-
213·8B
Aortocoronary bypass
Drug-Eluting Stents in the Treatment of Saphenous Vein 
Graft Disease: Poor Outcome in Diffusely Diseased 
Grafts##916-214·34B
Arteries
Role of Renal Function in Vascular Access Complication 
Rates in Patients Undergoing Percutaneous Coronary 
Procedures Using Arteriotomy Closure Devices##903-
212·6B
Aspirin
Effects of Aspirin Dose on Ischemic Events and Bleeding After 
Percutaneous Coronary Intervention: Insights From the 
PCI-CURE Study##2805-9·46B
Measures of Aspirin Resistance and Clopidogrel Resistance 
Do Not Correlate With Post-Percutaneous Coronary 
Intervention Markers of Myonecrosis##903-216·7B
Safety and Efficacy of Desensitization Procedure in Patients 
With Aspirin Sensitivity Undergoing Percutaneous 
Coronary Stenting##901-216·2B
Assisted circulation
Percutaneous Circulatory Support During High-Risk 
Angioplasty Procedures: A Multicenter Experience With 
Impella Technology##901-212·1B
Preliminary Experience of the MACH 2 Trial: Safety and 
Feasibility of Left Ventricular Support With the Impella 
LP 2.5 Device in Patients With Acute ST-Segment 
Elevation Myocardial Infarction##914-211·29B
Atherectomy
Rotational Atherectomy Prior to the Stenting With Sirolimus-
Eluting Stent for Diffuse In-Stent Restenosis: Multicenter 
Registry in Asia##903-215·7B
The Efficacy of Pre-Drug-Eluting Stent Debulking by 
Directional Atherectomy for Bifurcated Lesions: A 
Multicenter Prospective Registry##907-214·15B
Atherosclerosis
Morphologic Feature and Frequency of Coronary Pre-
Rupture Thin-Cap Fibroatheroma in Patients With Acute 
Myocardial Infarction and Stable Angina Pectoris: 
A Three-Vessel Optical Coherence Tomography 
Study##909-213·19B
Blood cells
Blood Transfusion is Independently Associated With Death in 
Acute Myocardial Infarction: Insights From APEX-AMI 
Trial##917-216·36B
Calcium
Characterization of the Intravascular Ultrasound 
Radiofrequency Signal Within Regions of Acoustic 
Shadowing Behind Calcium##914-213·29B
Cardiac surgery
Comparison of Mid-Term Results of Left Main Disease 
Treatment by Risk Stratification Systems##902-214·4B
Robust Impact of Chronic Kidney Disease on Long-Term 
Survival in Patients Undergoing Revascularization 
of Severe Unprotected Left Main Coronary Artery 
Stenosis##905-209·9B
Cardiac tamponade
Coronary Artery Perforations: Incidence, Predictors and 
Clinical Outcomes: Multicenter Registry in Japan##905-
212·10B
Cardiology practice/management
One-Year Results of Combined Embolic Protection and 
Thrombectomy in Percutaneous Coronary Intervention 
of Acute Myocardial Infarction Using the Proxis®-
Device##915-214·32B
Quality Improvement: Reducing Door-to-Balloon Times in 
Patients With ST Elevation Myocardial Infarction: The 
Penn State HVI Heart Alert Program##2803-9·43B
Cardiomyopathies, hypertrophic
Clinical and Angiographic Predictors of High-Degree 
Atrioventricular Block After Percutaneous Septal 
Myocardial Ablation: Multivariate Analysis of 65 
Consecutive Patients##902-213·4B
Immediate Improvement in Coronary Flow Reserve After 
Alcohol Septal Ablation in Patients With Hypertrophic 
Obstructive Cardiomyopathy##903-213·6B
Cardiovascular disease
Role of Renal Function in Vascular Access Complication 
Rates in Patients Undergoing Percutaneous Coronary 
Procedures Using Arteriotomy Closure Devices##903-
212·6B
Two-Year Outcomes in Real-World Experience With Taxus 
Paclitaxel-Eluting Stent in a Prospective, Multicenter, 
Consecutively-Enrolling United States Registry: ARRIVE 
1##904-211·8B
Carotid stenting
Carotid Artery Stent Type Influences Duplex Ultrasonography 
Derived Flow Velocities: Findings of an In Vitro 
Model##910-212·21B
Efficacy and Safety of Carotid Artery Stenting in Patients 
Scheduled for Cardiac Surgery##918-213·37B
Octogenarian Status Is an Independent Risk Factor for Adverse 
Outcomes After Carotid Stenting##916-212·33B
Safety and Efficacy of Carotid Artery Stenting in Patients With 
a History of Neck Irradiation##917-212·35B
Cells
Time-Dependent Inhibition of the Ischemia-Induced 
Mobilization of Bone Marrow Mesenchymal Stem Cells 
by Ischemic Preconditioning During Porcine Coronary 
Occlusion/Reperfusion##2803-3·42B
Central nervous system
Feasibility and Safety of Drug-Eluting Stent Implantaton in the 
Treatment of Stenosis of Vertebrobasilar Arteries##919-
212·39B
Clinical trials
A Prospective Registry to Evaluate an Implantation of 
Sirolimus-Eluting Stent in Bifurcation Lesions: 
Comparison of Simple-Versus Complex Stenting 
Techniques: Long-Term Clinical Outcome From the 
J-Cypher Registry##905-211·10B
Should Bivalirudin Be the Preferred Antithrombotic Agent of 
Choice During Elective or Urgent Percutaneous Coronary 
Intervention? A Bayesian Analysis of REPLACE-2 and 
ACUITY Trials##918-215·37B
Contrast media
Effect of Nesiritide on Kidney Function in Patients With 
Advanced Chronic Kidney Disease Undergoing Contrast 
Angiographic Procedures##904-209·7B
Is Contrast Medium Dose a Risk Factor for the Development 
of Contrast-Induced Nephropathy in Patients With 
Chronic Kidney Disease?##908-209·16B
Preventing Contrast-Induced Nephropathy in High-Risk 
Patients: Does the Contrast Agent Matter?##906-209·12B
Prevention of Radiocontrast Medium Induced Nephropathy 
Using High-Dose Statin in Patients Undergoing Coronary 
Angiography: The PROMISS Trial - A Randomized 
Controlled Study##2805-7·46B
The Effect of Contrast-Induced Nephropathy on Long-Term 
Renal Function##902-209·3B
The Incidence of Contrast-Induced Nephropathy With 
Iomeprol Is Similar to the Incidence of Contrast-Induced 
Nephropathy With Iopamidol##904-217·9B
Coronary artery disease
A Biomarker Fingerprint of Heightened Plaque Metabolism 
in Stable Angina Patients Undergoing Elective 
Percutaneous Coronary Intervention: Stable Angina Is Not 
Metabolically Stable##908-210·16B
A Novel Noninvasive Digital Arterial Pulse Wave Analysis 
During a Deep Breathing Exercise as an Indicator of 
Coronary Artery Disease##915-211·31B
A Prospective Multicenter Randomized Comparison 
of Paclitaxel Versus Sirolimus-Eluting Stents for 
Long Coronary Lesion: Six--Month Angiographic 
Follow-Up Study: Impact of Cilostazol on Neointimal 
Hyperplasia##906-211·12B
Acute Stent Recoil of Bioabsorbable Everolimus-Eluting 
Coronary Stent and Everolimus-Eluting Coronary 
Metal Stent: Insight From the ABSORB and SPIRIT 
Trials##911-211·23B
Are Angiographic Restenosis Criteria Functionally Relevant in 
Evaluation of Jailed Side Branch Lesions at Follow-Up 
Angiograms?##901-215·2B
Are Drug-Eluting Stents Superior to Bare Metal Stents in 
Large Coronary Arteries?##916-210·33B
Are Patients With Drug Eluting Stents at Increased Risk for 
Late Stent Thrombosis? Results From a Nested-Case-
Control Study##2804-3·43B
Arterial Revascularization Therapies Study Part II - Sirolimus-
Eluting Stents for the Treatment of Patients With 
Multivessel De Novo Coronary Artery Lesions: Three-
Year Clinical Outcomes##2804-15·45B
Can Rosuvastatin Administration Before Percutaneous 
Coronary Intervention Reduce the Periprocedural 
Myocardial Injury in Patients With Stable Angina? Results 
of a Randomized Study##907-216·16B
Characterization of the Intravascular Ultrasound 
Radiofrequency Signal Within Regions of Acoustic 
Shadowing Behind Calcium##914-213·29B
Circulating Secretory Phospholipase A2 Activity and Risk of 
Incident Coronary Events in Healthy Men and Women: 
The EPIC-NORFOLK Study##906-217·14B
Clinical Results of Percutaneus Coronary Intervention for 
Chronic Total Occlusion: Predictive Factor for Procedural 
Failure in Recent Technical Development and New Stiff 
Guidewire Era##904-210·8B
Cone Crush, Is a Variant of Modified T-Stenting Technique for 
Coronary Bifurcation Lesions: Bench Testing, Clinical 
Feasibility and In-Hospital Outcomes##903-214·6B
Coronary Artery Perforations: Incidence, Predictors and 
Clinical Outcomes: Multicenter Registry in Japan##905-
212·10B
Culotte Versus T-Stenting in Bifurcation Lesions: Immediate 
Clinical and Angiographic Results and Mid-Term Clinical 
Follow-Up##909-214·20B
Does Diabetic Mellitus Predict a Higher In-Hospital 
Mortality Following Percutaneous Saphenous Vein 
Graft Intervention in the Setting of Acute Myocardial 
Infarction?##916-216·34B
Durable Clinical Benefit Following Sirolimus-Eluting Stent 
Deployment on the Outcome of Patients With Chronic 
Total Occlusions-Multicenter Registry in Asia: Four-Year 
Results##903-210·5B
First Real-World Experience and 6-Month Clinical Outcome in 
Patients Treated With a GenousTM Endothelial Progenitor 
Cell Capturing Stent##907-211·15B
Five-Year Outcomes in a Cohort of Coronary Artery Disease 
Patients Treated With Percutaneous Coronary Intervention 
in the National Heart Lung and Blood Institute Dynamic 
Registry: Initial Acute Coronary Syndrome Is a Risk 
Factor for Future Ischemic Events##907-210·14B
Fractional Flow Reserve-Guided Side Branch Intervention 
Versus Conventional Intervention in Bifurcation Lesions: 
Comparison of Long-Term Clinical Outcomes##2802-
9·42B
High Restenosis Rate in Patients on Hemodialysis Treated 
With Either Sirolimus-Eluting Stents or Bare Metal 
Stents##911-209·22B
Impact of Plaque Composition on Troponin Elevation After 
Percutaneous Coronary Intervention: Virtual Histology-
Intravascular Ultrasound Analysis##903-217·7B
Impact of Renal Function on Coronary Plaque Characteristics 
in Patients With Acute Myocardial Infarction: An 
Intravascular Ultrasound Analysis##901-209·1B
Implications of Hemoglobin Decrease in the Absence 
of Overt Bleeding After Percutaneous Coronary 
Intervention##2805-3·45B
Initial Clinical Experience With Right Ventricular Endocardial 
Thermography in Transplanted and Coronary Artery 
Disease Patients.##919-211·39B
Initial Experience and Efficacy of the Retrograde Approach 
Technique for Chronic Total Occlusions##914-209·28B
Intermediate Volume Operators Attempt Percutaneous 
Coronary Intervention of Chronic Total Occlusions More 
Frequently Than Low-or High-Volume Operators: An 
Analysis From the American College of Cardiology-
National Cardiovascular Data Registry Database of 
45,826 CTO Patients##901-210·1B
Metabolic Syndrome as a Predictor of Restenosis in Diabetic 
Patients Presenting With Acute Coronary Syndrome or 
Angina##904-215·9B
Multiple Thin-Cap Fibroatheromas Assessed by Three-Vessel 
Histological and Optical Coherence Tomographic 
Study##911-213·23B
New Technology of Three-Dimensional Coronary Bifurcation 
Imaging##918-212·37B
New Value of Intraseptal Collateral for Percutaneous Coronary 
Intervention to Chronic Total Occlusion With Retrograde 
Approach##917-209·34B
Optimal Platelet Inhibition in Patients Undergoing 
Percutaneous Coronary Intervention: Data From the MR 
PCI Study##916-215·34B
Outcomes of Bivalirudin in Moderate-and High-Risk Patients 
With Acute Coronary Syndromes and Renal Insufficiency: 
An ACUITY Substudy##902-216·4B
Physiologic Evaluation of Myocardial Bridging: A New 
Analysis for an Old Disease##901-217·3B
Relationship Between the 3D Structure of the Left Main 
Coronary Artery Bifurcation and Double Stenting##2802-
7·41B
Robust Impact of Chronic Kidney Disease on Long-Term 
Survival in Patients Undergoing Revascularization 
of Severe Unprotected Left Main Coronary Artery 
Stenosis##905-209·9B
Safety and Efficacy of a New Guidewire for Crossing Chronic 
Total Occlusions: First in Man Results##918-210·36B
SPIRIT II Study: A Clinical Evaluation of the XIENCE 
V Everolimus Eluting Coronary Stent System in the 
Treatment of Patients with de Novo Native Coronary 
Artery Lesions##914-210·28B
Superficial Fibro-Fatty Area Detected by Virtual Histology 
Intravascular Ultrasound Is Associated With Thrombus 
Detected by Angioscopy##916-213·33B
The CROSSER Chronic Total Occlusion Recanalization 
System: Multicenter United States and European Study 
Results##915-209·30B
Three-Year Outcome of Intracoronary Stand-Alone Bolus 
Administration of Eptifibatide During Coronary 
Intervention##915-215·30B
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Trends in Outcomes Following Percutaneous Coronary 
Intervention for Chronic Total Occlusions: 25-Year 
Experience From the Mayo Clinic##2802-5·41B
Vulnerable and Stable Lesion Characteristics Assessed by 
Optical Coherence Tomography, Integrated-Backscatter 
Intravascular Ultrasound, Angioscopy, and 64-Slice Multi-
Detector Computed Tomography##913-213·27B
Coronary circulation
Immediate Improvement in Coronary Flow Reserve After 
Alcohol Septal Ablation in Patients With Hypertrophic 
Obstructive Cardiomyopathy##903-213·6B
Coronary heart disease
Is There a Lack of Initial Benefit With Drug Eluting 
Stents? Insights From 3-Year Follow-Up of ERACI III 
Study##2801-7·40B
Coronary microcirculation
Impact of Techniques to Reduce or Prevent Distal 
Embolization During Primary Percutaneous Coronary 
Intervention for Acute Myocardial Infarction: Meta-
Analysis of Randomized Clinical Trials##2803-7·43B
Randomized Evaluation of the Effect of Thrombus Aspiration 
by Two Different Thrombectomy Devices on Myocardial 
Blush During Primary Percutaneous Coronary 
Intervention##914-214·30B
Coronary sinus
Percutaneous Mitral Valve Annuloplasty for Ischemic Mitral 
Regurgitation: First in Man Experience With a Temporary 
Implant##905-213·10B
Coronary vessels
Acute Stent Recoil of Bioabsorbable Everolimus-Eluting 
Coronary Stent and Everolimus-Eluting Coronary 
Metal Stent: Insight From the ABSORB and SPIRIT 
Trials##911-211·23B
Preclinical Safety Evaluation of a Novel Helical Rotational 
Thrombectomy Device##917-211·35B
The Critical Role of Magnetic Resonance Angiography in 
Evaluation of Anomalous Coronary Arteries##911-
214·23B
Creatine kinase
Large Myocardial Infarction After Percutaneous Coronary 
Intervention: Secondary to Micro Embolization or Macro 
Mechanical Complications?##910-210·21B
Diabetes mellitus
A Prospective Randomized Antiplatelet Trial of Cilostazol 
Versus Clopidogrel in Patients With Diabetes Patients 
Who Underwent Drug-Eluting Stent Implantation##914-
215·30B
Does Diabetic Mellitus Predict a Higher In-Hospital 
Mortality Following Percutaneous Saphenous Vein 
Graft Intervention in the Setting of Acute Myocardial 
Infarction?##916-216·34B
Drug-Eluting Stents in Patients With Diabetes Mellitus: A 
Meta-Analysis of Randomized Trials##902-210·3B
Impact of Glycoprotein IIb/IIIa Inhibitors on Outcomes of 
Diabetic Patients Undergoing Percutaneous Coronary 
Interventions With Sirolimus-Eluting Stents##916-
209·32B
Metabolic Syndrome as a Predictor of Restenosis in Diabetic 
Patients Presenting With Acute Coronary Syndrome or 
Angina##904-215·9B
Preventing Contrast-Induced Nephropathy in High-Risk 
Patients: Does the Contrast Agent Matter?##906-209·12B
The Importance of Fundoscopy for the Interventional 
Cardiologist##919-209·38B
Diagnostic techniques
A Novel Noninvasive Digital Arterial Pulse Wave Analysis 
During a Deep Breathing Exercise as an Indicator of 
Coronary Artery Disease##915-211·31B
Morphologic Feature and Frequency of Coronary Pre-
Rupture Thin-Cap Fibroatheroma in Patients With Acute 
Myocardial Infarction and Stable Angina Pectoris: 
A Three-Vessel Optical Coherence Tomography 
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